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Summary
Rationale
There is evidence that lung function in infancy predicts childhood wheeze. However, very few studies have both measured premorbid lung function in early infancy and considered clinically significant childhood wheeze phenotypes. Consequently, it is unclear whether early lung development is most closely associated with atopic or non-atopic preschool wheeze.
Objective
To examine the association between premorbid infant lung function and preschool wheeze according to atopic or non-atopic wheeze phenotype.
Methods
Infant lung function was measured in 147 healthy term infants aged 5-14 weeks. Rapid thoracoabdominal compression was performed during tidal breathing and at raised volume to measure maximal expiratory flow at functional residual capacity (V'maxFRC) and forced expiratory volume in 0.4 sec (FEV0.4). Atopic status was determined by skin prick testing at 3 years and wheeze ascertained from parental questionnaires (1 and 3 years).
Measurements and Main Results
Lower early infancy V'maxFRC was associated with wheeze in both the first and third years of life (p=0.002 and p=0.006, respectively). Lower early infancy FEV0.4 was associated with wheeze in infancy (p=0.03). Compared to non-atopic children who did not wheeze, nonatopic children who wheezed in their third year of life had lower FEV0.4, (p=0.02), whilst atopic children who did and did not wheeze had similar FEV0.4 (p=0.4).
Introduction
Lower infant lung function is a risk factor for wheeze in infancy and early childhood [1] [2] [3] [4] [5] .
Previous studies have demonstrated abnormalities of infant lung function are present in those children who subsequently experience wheeze and these abnormalities can be detected prior to the first wheezing illness [1] [2] [3] [4] . The results of longer-term follow up studies are less consistent.
Although tracking of lung function from infancy, through childhood 6 and into adult life 7 is well described, the relationship between early lung function and phenotypes of wheezing illness is less clear. The Tucson study, for example, found reduced V'maxFRC to be associated with a transient wheeze phenotype in 125 infants assessed at a mean age 2.4 months (SD 2 months), but no association was found with wheezing after 3 years of age 8 . In contrast, other studies suggest early impairment of lung function is a risk factor for wheeze which persists into later childhood 6:9 .
The original 'wheeze phenotypes' described in the Tuscon study were defined retrospectively according to age of onset and persistence of symptoms 8 Premorbid infant lung function may reflect early environmental or genetic influences.
Common genetic polymorphism is known to impact neonatal disease and outcome 13 .
ADAM33 is a positionally cloned asthma susceptibility gene that shows strongest linkage with a combined asthma and bronchial hyperresponsiveness phenotype 14 . ADAM33 is expressed in lung fibroblasts and bronchial smooth muscle and is expressed during embryonic lung development 15 . Previously, ADAM33 polymorphisms have been associated with impaired lung function at 3 years of age, specifically deficits in FEV1 and carriers homozygous for the A allele of F+1 SNP had double the risk of transient early wheeze 16 .
Associations between a number of individual SNPs and both baseline lung function and non atopic asthma have also been demonstrated in a population of German school children 17 .
The Southampton Women's Survey (SWS) was the first to measure premorbid FEV0.4 in a longitudinal pregnancy cohort study 18 . The rapid thoracoabdominal compression (RTC) technique has been used for many years to measure V'maxFRC in infants. Concerns about intersubject and intrasubject variability led to a modification of the method, performing the manoeuvre at raised volume (RV-RTC), removing the use of a variable volume landmark 19 . It has been suggested that measurement of FEV0.5 using RVRTC is more sensitive at detecting impaired airway function than V'maxFRC in infants with CF prior to respiratory symptoms 20;21 .
This is the first study to investigate the predictive value of infant FEV0.4 in healthy term infants in relation to future wheeze. Using this outcome measure, we aimed to test the hypothesis that lower infant lung function is associated with preschool wheeze and to explore 3 the associations between premorbid infant lung function and preschool wheeze according to atopic phenotype. As a secondary aim, we explored the relationship between ADAM33 polymorphism, lung function in infancy and preschool wheeze.
Methods
Participants
The Southampton and South West Hampshire Local Research Ethics Committee approved the protocol and written consent was obtained from the children's mothers. Detailed information regarding the participants and infant lung function testing have been described 18 . In brief,
Caucasian infants, born at least 37 weeks gestation without major congenital anomalies and prior to any respiratory infection were recruited from the SWS, a population-based pregnancy cohort 22 . 362+ women were approached about the study; 219+ (60%) declined. Of those who Lung function was measured, with infants lying supine, in quiet sleep augmented with chloral hydrate (75-100 mg/kg). An inflatable jacket connected to a rapid inflation system was placed around the infant's chest and abdomen and a leak-free facemask with Fleisch pneumotachograph (Dynasciences, Blue Bell, CA) was held over the nose and mouth. Data were collected using RASP software (Physiologic Ltd, Newbury, Berks, UK) and analysed in SQUEEZE (Paul Dixon, London).
As previously described 18 , respiratory rate was measured during tidal breathing. To record partial expiratory flow volume curves, a stable end expiratory level was established before performing an RTC at the lowest pressure to achieve the best V'maxFRC, calculated from the partial expiratory flow volume curve. Passive, relaxed inflations to 30cm water were recorded 5 using a resuscitator connected to the pneumotachograph. The airway opening pressure was measured during occlusion which causes the respiratory muscles to relax by the Hering Breuer reflex and airway pressure to equilibrate with alveolar pressure; this in turn represents the summed elastic recoil pressure of the lung and chest wall. Compliance of the respiratory system (Crs) was calculated using SQUEEZE from the resultant passive flow-volume curves as change in volume for unit of airway outlet pressure (ml/mm water). Raised volume RTC curves were recorded at the optimal jacket pressure at the end of a passive inspiration using a technique adapted from Feher and colleagues 19 , and FEV0.4 and FVC were measured from the forced expiratory flow-volume curve. Genotyping DNA was isolated from cord blood using a salting-out procedure 23 . The following five SNPs were chosen for genotyping as they span the ADAM33 gene region (based on the LDU map from Simpson et al 16 ). ADAM33 SNPs Bp1 (rs487377), Fp1 (rs511898), STp7 (rs574174), Vm3 (rs628977), V4 (rs2787094) were genotyped by TaqMan SNP genotyping assays (ETable1).
Statistical Analysis
The infant lung function data were logarithmically transformed to achieve normality and adjusted for age and sex where necessary. During the first year of life, 74 infants had at least one episode of wheezing. Thirty three children experienced wheeze in the third year of life, of these 23 had also experienced wheeze in the first year of life whilst 10 had not. Of the 113 children who were skin prick tested for allergy, 20 (17.7%) had at least one positive reaction and were classed as atopic. Of the children who experienced wheeze 25% were atopic and 75% were not.
The demographic characteristics of those children reporting wheeze at 3 years and those that did not are listed in table 1. Comparing children who did and did not wheeze, there were no differences in gender or the mother's age, atopy but those who wheezed at 3 years were more likely to have a mother who smoked during pregnancy. However, those who wheezed in the 8 first year of life were more likely to be born to younger mothers and have mothers who had smoked in pregnancy than those who did not wheeze (data not shown).
Associations between wheeze or wheeze phenotype and lung function were examined after adjusting for factors that were found to influence measures of lung function on univariate analysis. FEV0.4, and V'maxFRC were adjusted for gender and Crs for gender and age at testing.
Relationship between infant lung function and respiratory symptoms reported at age 1 year V'maxFRC, FEV0.4 and Crs were lower in infants who subsequently wheezed in their first year than in those who did not by 22.5% (p=0.002), 8.1% (p=0.03) and 6.8% (p=0.04) respectively (Table 2 ). The group mean respiratory rate was 6.8% higher in the wheeze group than in the non-wheeze group (p=0.03).
Relationship between infant lung function and respiratory symptoms reported at age 3 years V'maxFRC was 23.2% lower in infants who wheezed in their third year than in those who did not (Table 2 ) (p=0.006). However, there were only small non-significant differences in FEV0.4, Crs and respiratory rate between the two groups. When non-atopic children were considered separately from atopic individuals, FEV0.4 was 11% lower in those who wheezed (p=0.02) ( Table 3 ). There were no significant differences in any measure of infant lung function when atopic children with wheeze in the third year were compared to non-atopic children without wheeze (Table 3) .
ADAM33 SNP haplotype analysis
No ADAM33 SNP haplotype was significantly associated with infant lung function measurements after adjusting for multiple testing by Bonferroni correction (E-Table3).
Haplopower analysis (Online Data Supplement) revealed that with the small sample size (n = 82) we were underpowered (Power = 19%) to detect a common haplotype (freq = 18%) association accounting for 5% of the variance in the mean of the Crs measurement.
Discussion
This study demonstrates an association between impaired premorbid infant lung function and preschool wheezing illness. This confirms the results of previous studies 4;5 . Our analyses show for the first time that lower lung function in early infancy is a risk factor for non-atopic wheeze, rather than atopic wheeze. Additionally, this study is the first to report reduced FEV0.4, prior to lower respiratory infection, as a risk factor for wheeze in the preschool years.
This is particularly important in view of recent work demonstrating that diminished timed forced expiratory volumes are an important predictor of all-cause mortality in adult life 26 . As with other studies of infant lung function, this study is of low power due to the heavy technical investment required to produce high quality measurements. is well suited to longitudinal study as it is intuitively more comparable to the measures of lung function, such as FEV1, which are used in older children and adults.
The results of this study are of relevance to the general population. We recruited healthy infants and only excluded those born before 37 weeks gestation to prevent bias due to effects 11 of prematurity upon lung development. Our results demonstrate that variations in measures of expiratory flow measured in unselected populations are associated with preschool wheeze.
Small study numbers limited the exploration of lung function measures according to wheeze phenotype. However, a significant difference in FEV0.4 was noted in non-atopic children who wheezed during the third year of life compared to non-atopic children without wheeze. There was no difference in any measure of infant lung function when atopic children with wheeze in the third year were compared to non-atopic children without wheeze. This may have been partly related to greater power associated with a more balanced distribution of non-atopic than atopic individuals between the wheeze and no wheeze groups. However, others have speculated that wheezing during the first year of life is often a transient condition due to reduced airway caliber and that wheeze beginning or persisting into later childhood is more likely to be due to the wheeze phenotype recognised as asthma 4 .
Due to the number of subjects studied it was not possible to analyse our data according to age of onset. However, the broader confidence intervals and divergence of results between atopic and non-atopic individuals at age three years may be evidence of comparative heterogeneity of wheeze phenotypes later in childhood. The strong association between reduced measures of forced expiratory flow and wheeze at one year may reflect a common underlying mechanism, similar to that proposed by Martinez, whereby initial airway diameter, length or other characteristics might predispose certain infants to wheezing with viral respiratory infections 3 .
With growth this may resolve in some infants as airway size increases but for those with the smallest airway dimensions the risk of non-atopic wheeze may persist. In contrast, airway dimensions at birth may be less significant in the aetiology of atopic wheeze compared to other factors acquired in association with an atopic phenotype.
As described earlier, ADAM33 is expressed in the embryonic lung 15 and SNPs in the gene encoding ADAM33 were previously found to predict impaired lung function at age 3 and 5 years 16 . However, it is unclear whether ADAM33 polymorphism is associated with abnormal lung function at birth (reflecting altered in utero lung development) or whether post-natal gene-environment interaction alters lung function and increases risk of asthma. Recent observations from the PIAMA birth cohort show that in utero, but not post natal, cigarette smoke exposure interacts with ADAM33 polymorphism to determine childhood lung function and BHR would suggest that ADAM33 polymorphism may alter in utero lung development 28 .
In the current study, no ADAM33 haplotype was associated at the 5% level with lung function or symptoms in the first or third years of life after correction for multiple testing.
Simpson et al. described that the F+1 polymorphism explained 3% of the variance in lung function (sRaw) at 3 years of age 16 ; power calculations show that we only had 19% power to detect an association that predicts 5% variance in Crs measurements. Given the observation of interaction with in utero smoke exposure and the trend towards association seen in the current study, the association between ADAM33 haplotypes and infant lung function needs to be examined in a meta-analysis of data from all available infant lung function cohorts.
Strengths and limitations of this study
We successfully measured infant lung function in 147 infants; the robust FEV0.4 measurement was recorded in 98 infants, and 141 children (96%) were followed up to age 3 years.
Although the number of infants recruited to this study was small it is comparable to the numbers recruited to similar cohort studies 4;5 18 . A second source of potential bias relates to exclusion of children on the basis of respiratory infection prior to lung function measurement. This exclusion was used to ensure that the effects of premorbid lung function upon later wheeze status were explored and to avoid bias by postnatal effects. This would only bias the result if the relationship between infant lung function and later wheeze differed between those infants who experienced early infection and those who did not. There is no reason to believe that this relationship would differ in a manner which would decrease the strength of the association between poor infant lung function and later wheeze; that is to say it is unlikely infants suffering early respiratory infection would have a better outcome in terms of later wheeze than those that did not experience early infections.
In summary this study has shown a significant relationship between early life lung function and respiratory symptoms in the first and third years of life. Lower FEV0.4 in early infancy was associated with non-atopic wheeze but not atopic wheeze at 3 years of age. This is further evidence suggesting that pre-natal factors contribute to the development of wheeze in early life. 
